Over 150 organizations, including major health systems, have urged U.S. Attorney General Pam Bondi to revise the DEA’s proposed telemedicine prescribing framework, citing concerns that it imposes excessive restrictions. The letter emphasizes the need for safe access to controlled substances via telemedicine, and advocates for a balanced approach that prioritizes patient care while preventing substance misuse.
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is
